Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Selena Khanal
Observed name:
Khanal, Selena
Institutions:
The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute,
The Ohio State University
Observed institutions:
The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute,
The Ohio State University
ORCID:
0009-0002-1054-4426
Observed ORCID:
0009-0002-1054-4426
OpenAlex ID:
A5130500473
Advanced CD276-Targeting Dual-Payload Antibody–Drug Conjugates for Cancer Therapy
2026
·
Zhuoxin Zhou
, Davis Ballard
, et al.
·
Cancer Research Communications
·
2
Humanized Antibody–Drug Conjugates for Somatostatin Receptor 2–Positive Tumor Treatment
2026
·
Zhuoxin Zhou
, Zhantao Du
, et al.
·
Molecular Cancer Therapeutics
Figure 1 from Advanced CD276-Targeting Dual-Payload Antibody–Drug Conjugates for Cancer Therapy
2026
·
Zhuoxin Zhou
, Davis Ballard
, et al.
Data from Advanced CD276-Targeting Dual-Payload Antibody–Drug Conjugates for Cancer Therapy
2026
·
Zhuoxin Zhou
, Davis Ballard
, et al.
Figure 2 from Advanced CD276-Targeting Dual-Payload Antibody–Drug Conjugates for Cancer Therapy
2026
·
Zhuoxin Zhou
, Davis Ballard
, et al.
Figure S4 from Advanced CD276-Targeting Dual-Payload Antibody–Drug Conjugates for Cancer Therapy
2026
·
Zhuoxin Zhou
, Davis Ballard
, et al.
Figure 3 from Advanced CD276-Targeting Dual-Payload Antibody–Drug Conjugates for Cancer Therapy
2026
·
Zhuoxin Zhou
, Davis Ballard
, et al.
Figure S3 from Advanced CD276-Targeting Dual-Payload Antibody–Drug Conjugates for Cancer Therapy
2026
·
Zhuoxin Zhou
, Davis Ballard
, et al.
Figure S1 from Advanced CD276-Targeting Dual-Payload Antibody–Drug Conjugates for Cancer Therapy
2026
·
Zhuoxin Zhou
, Davis Ballard
, et al.
Figure S2 from Advanced CD276-Targeting Dual-Payload Antibody–Drug Conjugates for Cancer Therapy
2026
·
Zhuoxin Zhou
, Davis Ballard
, et al.
Figure 5 from Advanced CD276-Targeting Dual-Payload Antibody–Drug Conjugates for Cancer Therapy
2026
·
Zhuoxin Zhou
, Davis Ballard
, et al.
Figure S7 from Advanced CD276-Targeting Dual-Payload Antibody–Drug Conjugates for Cancer Therapy
2026
·
Zhuoxin Zhou
, Davis Ballard
, et al.
Figure S6 from Advanced CD276-Targeting Dual-Payload Antibody–Drug Conjugates for Cancer Therapy
2026
·
Zhuoxin Zhou
, Davis Ballard
, et al.
Figure 4 from Advanced CD276-Targeting Dual-Payload Antibody–Drug Conjugates for Cancer Therapy
2026
·
Zhuoxin Zhou
, Davis Ballard
, et al.
Table 1 from Advanced CD276-Targeting Dual-Payload Antibody–Drug Conjugates for Cancer Therapy
2026
·
Zhuoxin Zhou
, Davis Ballard
, et al.
Figure 7 from Advanced CD276-Targeting Dual-Payload Antibody–Drug Conjugates for Cancer Therapy
2026
·
Zhuoxin Zhou
, Davis Ballard
, et al.
Figure 6 from Advanced CD276-Targeting Dual-Payload Antibody–Drug Conjugates for Cancer Therapy
2026
·
Zhuoxin Zhou
, Davis Ballard
, et al.
Figure S5 from Advanced CD276-Targeting Dual-Payload Antibody–Drug Conjugates for Cancer Therapy
2026
·
Zhuoxin Zhou
, Davis Ballard
, et al.
Reproducible Computational Analysis for Advanced Dual Payload Antibody-Drug Conjugates
2026
·
Zhuoxin “Zora” Zhou
, Ballard, Davis
, et al.
·
Code Ocean
Reproducible Computational Analysis for Advanced Dual Payload Antibody-Drug Conjugates
2026
·
Zhuoxin “Zora” Zhou
, Ballard, Davis
, et al.
·
Code Ocean
Humanized antibody-drug conjugates for SSTR2-positive tumor treatment
2026
·
Zhuoxin Zhou
, Zhantao Du
, et al.
·
Code Ocean
Show more works
View as search
Works count:
21
Citation count:
2
H-index:
1
I10-index:
Year
Topic
Type